#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrointestinal cancer metastatic Lupus nephritis Medulloblastoma recurrent Mantle cell lymphoma stage III Ovarian cancer Acute myeloid leukaemia Immunoglobulin G4 related disease Necrotising myositis Metastatic malignant melanoma Anti-HLA antibody test positive Mucopolysaccharidosis I Neurotrophic keratopathy Oesophageal adenocarcinoma stage II Oropharyngeal cancer recurrent Stress cardiomyopathy More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Treatment Epidermolysis bullosa – Basic Information Congenital hypotransferrinaemia Congenital nephrogenic diabetes insipidus – Diagnostics Fabry’s disease Mucopolysaccharidosis II – Trials in Disease Lymphatic malformation – Diagnostics Glycogen storage disease type I Adrenocortical carcinoma – Diagnostics Glomerulonephritis membranoproliferative – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Letetresgene Autoleucel Radiprodil Delafloxacin Pembrolizumab Flutafuranol (18F) Irbesartan Thiamine Nitrate Bp Gt005 ANUMIGILIMAB FOSFOMYCIN CALCIUM Tiotropium Bromide IPN01195 Zolbetuximab Human Coagulation Factor Ii Riluzole Transpocart19 Rasagiline Mrna-4157 Retinol Acetate Carcik-Cd19 Cells More therapies…

    Learn about Your Condition

    Ebola disease Ankylosing spondylitis Neuroblastoma Hyperparathyroidism primary Thymic carcinoma Laryngeal cancer stage II Vascular malformation Muscle injury Ovarian epithelial cancer Erythema Incisional hernia Kearns-Sayre syndrome Polycythaemia vera Carpal tunnel syndrome B-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Sepsis

  • Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Anakinra
    • Filgrastim
    France

  • Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Ampicillin Sodium
    • Benzathine Benzylpenicillin
    • BENZYLPENICILLIN POTASSIUM
    Norway

  • Study on Meropenem Dosing for Patients with Serious Infections in Intensive Care

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Linezolid
    Norway

  • Study on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Meropenem Trihydrate
    • Meropenem
    • Ceftazidime Pentahydrate
    The Netherlands

  • Study on Early Clarithromycin Treatment to Prevent Sepsis in Patients with Community-Acquired Pneumonia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Clarithromycin
    Greece

  • Study Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    • Sepsis
    Investigated Drugs:
    • Piperacillin Sodium
    • Tazobactam Sodium
    • Linezolid
    Denmark Sweden
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!